Sickness rate and disability resulting from diseases of the nervous system: leading factors and ways of prevention
Journal Title: Медичні перспективи - Year 2013, Vol 18, Issue 3
Abstract
Over the past 10 years the total number of patients with diseases of the nervous system in Europe makes up 127,200,000 people, that is almost 25,8 % of the population have neurological pathology. Currently in Ukraine 1 654 875 patients with different neurological disorders are registered, in 78 % of cases disability develops which substantially worsens quality of life. By the assessment of WHO in 2012, more than 1 billion people are disabiled (15 % of the world population), of them – 2,8 million people are in Ukraine. Nervous diseases and their consequences will occupy the leading cause of disability among able-bodied population before 2020. The socio-economic aspect of the problem lies in the fact that by indices of person-years of life (index DALY) WHO evaluates disability as the global burden of diseases for the society, and most of the authors consider prevention of disability as the most economically expedient medical intervention. On this basis state Program «Health 2020: Ukrainian dimension» was approved considering new statutes of the new European politics, international experience on prevention of diseases and disability.
Authors and Affiliations
A. Kyrychenko
Dnipro Pharmacology School: a 100 years’ journey (to the centenial of the department of pharmacology and clinical pharmacology of Dnipropetrovsk medical academy). Part I: 1918-1943.
The article presents analysis of the main historical stages of the establishing and development of the scientific school of pharmacology of the SE "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" for a 100-...
Фиброз костного мозга – основа миелофиброза: патогенез, прогностическое значение и обоснование антифиброгенных лечебных стратегий
Фіброз кісткового мозку - основа мієлофіброзу: патогенез, прогностичне значення та обґрунтування антифіброгенних лікувальних стратегій. Тимченко А.С., Залеський В.М. Фіброз кісткового мозку, як патологічний процес, є ос...
Влияние L-лизина эсцината, тиотриазолина, гордокса и мидокалма на кислотно-основное состояние и ограниченный протеолиз в кишечной венозной крови в условиях моделирования интраабдоминальной гипертензии
У гострих експе¬риментах на кроликах вивчено напругу кисню в стiнцi кишечнику, змiни кислотно-лужного стану, а також обмеженого протеолiзу та його iнгiбiторiв у кишечнiй венознiй кровi та захисну дiю щодо цих змiн L-лiзи...
Roflumilast, ursodeoxycholic acid and nucleinate efficiency in patients with chronic obstructive pulmonary disease with accompanying chronic non-stone cholecystitis
Global Initiative for diagnosis, treatment and prevention of COPD has recently included roflumilast (R) - an inhibitor of phosphodiesterase-4 (PDE-4) as a new therapeutic agent to the recommendations for the management o...
Анализ состояния окружающей среды техногенного региона и ее опасности для здоровья населения
Мета роботи - дати комплексну гігієнічну оцінку стану основних об'єктів екологічного середовища Донецького регіону і визначити ступінь їх потенційної небезпеки для здоров'я населення. У зв’язку з цим проведена комплексна...